精神病的生物标志物:我们到了吗?对 1478 种生物标志物的总体回顾。

Schizophrenia bulletin open Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI:10.1093/schizbullopen/sgae018
Paola Fuentes-Claramonte, Andrés Estradé, Aleix Solanes, Valentina Ramella-Cravaro, Maria Angeles Garcia-Leon, Javier de Diego-Adeliño, Conrad Molins, Eric Fung, Marc Valentí, Gerard Anmella, Edith Pomarol-Clotet, Dominic Oliver, Eduard Vieta, Joaquim Radua, Paolo Fusar-Poli
{"title":"精神病的生物标志物:我们到了吗?对 1478 种生物标志物的总体回顾。","authors":"Paola Fuentes-Claramonte, Andrés Estradé, Aleix Solanes, Valentina Ramella-Cravaro, Maria Angeles Garcia-Leon, Javier de Diego-Adeliño, Conrad Molins, Eric Fung, Marc Valentí, Gerard Anmella, Edith Pomarol-Clotet, Dominic Oliver, Eduard Vieta, Joaquim Radua, Paolo Fusar-Poli","doi":"10.1093/schizbullopen/sgae018","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and hypothesis: </strong>This umbrella review aims to comprehensively synthesize the evidence of association between peripheral, electrophysiological, neuroimaging, neuropathological, and other biomarkers and diagnosis of psychotic disorders.</p><p><strong>Study design: </strong>We selected systematic reviews and meta-analyses of observational studies on diagnostic biomarkers for psychotic disorders, published until February 1, 2018. Data extraction was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Evidence of association between biomarkers and psychotic disorders was classified as convincing, highly suggestive, suggestive, weak, or non-significant, using a standardized classification. Quality analyses used the Assessment of Multiple Systematic Reviews (AMSTAR) tool.</p><p><strong>Study results: </strong>The umbrella review included 110 meta-analyses or systematic reviews corresponding to 3892 individual studies, 1478 biomarkers, and 392 210 participants. No factor showed a convincing level of evidence. Highly suggestive evidence was observed for transglutaminase autoantibodies levels (odds ratio [OR] = 7.32; 95% CI: 3.36, 15.94), mismatch negativity in auditory event-related potentials (standardized mean difference [SMD] = 0.73; 95% CI: 0.5, 0.96), P300 component latency (SMD = -0.6; 95% CI: -0.83, -0.38), ventricle-brain ratio (SMD = 0.61; 95% CI: 0.5, 0.71), and minor physical anomalies (SMD = 0.99; 95% CI: 0.64, 1.34). Suggestive evidence was observed for folate, malondialdehyde, brain-derived neurotrophic factor, homocysteine, P50 sensory gating (P50 S2/S1 ratio), frontal <i>N</i>-acetyl-aspartate, and high-frequency heart rate variability. Among the remaining biomarkers, weak evidence was found for 626 and a non-significant association for 833 factors.</p><p><strong>Conclusions: </strong>While several biomarkers present highly suggestive or suggestive evidence of association with psychotic disorders, methodological biases, and underpowered studies call for future higher-quality research.</p>","PeriodicalId":94380,"journal":{"name":"Schizophrenia bulletin open","volume":"5 1","pages":"sgae018"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369642/pdf/","citationCount":"0","resultStr":"{\"title\":\"Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers.\",\"authors\":\"Paola Fuentes-Claramonte, Andrés Estradé, Aleix Solanes, Valentina Ramella-Cravaro, Maria Angeles Garcia-Leon, Javier de Diego-Adeliño, Conrad Molins, Eric Fung, Marc Valentí, Gerard Anmella, Edith Pomarol-Clotet, Dominic Oliver, Eduard Vieta, Joaquim Radua, Paolo Fusar-Poli\",\"doi\":\"10.1093/schizbullopen/sgae018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and hypothesis: </strong>This umbrella review aims to comprehensively synthesize the evidence of association between peripheral, electrophysiological, neuroimaging, neuropathological, and other biomarkers and diagnosis of psychotic disorders.</p><p><strong>Study design: </strong>We selected systematic reviews and meta-analyses of observational studies on diagnostic biomarkers for psychotic disorders, published until February 1, 2018. Data extraction was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Evidence of association between biomarkers and psychotic disorders was classified as convincing, highly suggestive, suggestive, weak, or non-significant, using a standardized classification. Quality analyses used the Assessment of Multiple Systematic Reviews (AMSTAR) tool.</p><p><strong>Study results: </strong>The umbrella review included 110 meta-analyses or systematic reviews corresponding to 3892 individual studies, 1478 biomarkers, and 392 210 participants. No factor showed a convincing level of evidence. Highly suggestive evidence was observed for transglutaminase autoantibodies levels (odds ratio [OR] = 7.32; 95% CI: 3.36, 15.94), mismatch negativity in auditory event-related potentials (standardized mean difference [SMD] = 0.73; 95% CI: 0.5, 0.96), P300 component latency (SMD = -0.6; 95% CI: -0.83, -0.38), ventricle-brain ratio (SMD = 0.61; 95% CI: 0.5, 0.71), and minor physical anomalies (SMD = 0.99; 95% CI: 0.64, 1.34). Suggestive evidence was observed for folate, malondialdehyde, brain-derived neurotrophic factor, homocysteine, P50 sensory gating (P50 S2/S1 ratio), frontal <i>N</i>-acetyl-aspartate, and high-frequency heart rate variability. Among the remaining biomarkers, weak evidence was found for 626 and a non-significant association for 833 factors.</p><p><strong>Conclusions: </strong>While several biomarkers present highly suggestive or suggestive evidence of association with psychotic disorders, methodological biases, and underpowered studies call for future higher-quality research.</p>\",\"PeriodicalId\":94380,\"journal\":{\"name\":\"Schizophrenia bulletin open\",\"volume\":\"5 1\",\"pages\":\"sgae018\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369642/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Schizophrenia bulletin open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/schizbullopen/sgae018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia bulletin open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/schizbullopen/sgae018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景与假设:本综述旨在全面综合外周、电生理、神经影像学、神经病理学和其他生物标志物与精神病性障碍诊断之间的关联证据:我们选择了截至 2018 年 2 月 1 日发表的有关精神病性障碍诊断生物标志物的观察性研究的系统综述和荟萃分析。数据提取按照系统综述和荟萃分析首选报告项目(PRISMA)指南进行。生物标志物与精神障碍之间的关联证据采用标准化分类法分为有说服力、高度提示性、提示性、弱或无意义。质量分析采用了多重系统综述评估(AMSTAR)工具:总综述包括 110 项元分析或系统综述,涉及 3892 项单项研究、1478 个生物标志物和 392 210 名参与者。没有一个因素显示出令人信服的证据水平。转谷氨酰胺酶自身抗体水平(几率比 [OR] = 7.32;95% CI:3.36, 15.94)、听觉事件相关电位的错配负性(标准化平均差 [SMD] = 0.73;95% CI:0.5,0.96)、P300 分量潜伏期(SMD =-0.6;95% CI:-0.83,-0.38)、脑室-脑比率(SMD =0.61;95% CI:0.5,0.71)和轻微身体异常(SMD =0.99;95% CI:0.64,1.34)。叶酸、丙二醛、脑源性神经营养因子、同型半胱氨酸、P50 感觉门控(P50 S2/S1 比值)、额叶 N-乙酰天门冬氨酸和高频心率变异性均有提示性证据。在其余的生物标志物中,626 个因素的相关性证据不足,833 个因素的相关性不显著:结论:虽然一些生物标志物提供了与精神病性障碍相关的高度提示性或提示性证据,但方法学上的偏差和低效研究要求未来进行更高质量的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers.

Background and hypothesis: This umbrella review aims to comprehensively synthesize the evidence of association between peripheral, electrophysiological, neuroimaging, neuropathological, and other biomarkers and diagnosis of psychotic disorders.

Study design: We selected systematic reviews and meta-analyses of observational studies on diagnostic biomarkers for psychotic disorders, published until February 1, 2018. Data extraction was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Evidence of association between biomarkers and psychotic disorders was classified as convincing, highly suggestive, suggestive, weak, or non-significant, using a standardized classification. Quality analyses used the Assessment of Multiple Systematic Reviews (AMSTAR) tool.

Study results: The umbrella review included 110 meta-analyses or systematic reviews corresponding to 3892 individual studies, 1478 biomarkers, and 392 210 participants. No factor showed a convincing level of evidence. Highly suggestive evidence was observed for transglutaminase autoantibodies levels (odds ratio [OR] = 7.32; 95% CI: 3.36, 15.94), mismatch negativity in auditory event-related potentials (standardized mean difference [SMD] = 0.73; 95% CI: 0.5, 0.96), P300 component latency (SMD = -0.6; 95% CI: -0.83, -0.38), ventricle-brain ratio (SMD = 0.61; 95% CI: 0.5, 0.71), and minor physical anomalies (SMD = 0.99; 95% CI: 0.64, 1.34). Suggestive evidence was observed for folate, malondialdehyde, brain-derived neurotrophic factor, homocysteine, P50 sensory gating (P50 S2/S1 ratio), frontal N-acetyl-aspartate, and high-frequency heart rate variability. Among the remaining biomarkers, weak evidence was found for 626 and a non-significant association for 833 factors.

Conclusions: While several biomarkers present highly suggestive or suggestive evidence of association with psychotic disorders, methodological biases, and underpowered studies call for future higher-quality research.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.90
自引率
0.00%
发文量
0
期刊最新文献
Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial. Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms. Cognitive Impairment Associated With Schizophrenia: New Research Agenda. Negative Symptoms and Their Associations With Other Clinical Variables and Working Memory Across the Schizophrenia Spectrum and Bipolar Disorder. Association Between Juvenile Psychotic Experiences and Problematic Gaming.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1